Outcomes of multidisciplinary team for epilepsy management at Setthathirat hospital LAO

Phase 1

Completed

• Conditions: Help control seizures in patients with epilepsy; OMDTFEMSHL; OMDTFEMSH

• Registration Number: TCTR20231102007
• Lead Sponsor: Faculty of Pharmacy Mahasarakham University

Brief Summary

Before receiving MDT care at visit 1(month 0), the patient's adherence was low, knowledge scores were low, with a high percentage of seizure frequency, and high number of DRPs, and low quality of life scores. Subsequently, after receiving MDT care at visit 2 (month 3) the patient's adherence scores, and knowledge scores were increased, the percentage of seizures decreased, and the total number of DRPs decreased. Quality of life increases compared to before visit 1 (month 0) and after visit 3 (month 6).

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-08-10
• Study Start: 2023-11-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

1. The patients aged 18 years or older
2. Diagnosed with epilepsy by a physician
3. The patients had to receive antiepileptic drugs for at least 1 month and continue antiepileptic drugs for a minimum of 6 months
4. The patient had the ability to read and write the Lao language
5. The patient was agreeable to being the participant and willing to provide a written informed consent form.

Exclusion Criteria

1. Patient who has co-morbid: cancer, psychiatric, or neurological diseases
2. Pregnancy patients
3. Mentally retarded patients who cannot give information

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The adherence medication 6 months Patients adherence assessment tool was used pill-count and self-report of how to take medicine.

Secondary Outcome Measures

Name	Time	Method
knowledge, Seizure frequency, Drug-related problems, quality of life 6 months by using questions